Targeting Mitochondria 2020 will be a Virtual and In-Person Congress


We have been closely following updates and evolving guidance from local, national and global agencies for COVID-19. There is still much uncertainty around the coronavirus, and how long our communities may be impacted by the pandemic, but it seems certain that decisions about how we work, travel and gather together will continue to be influenced for weeks and months still to come. Today, we have made the decision to combine the In-Person and Virtual conference.


If you cannot attend in-person or virtual due to the restriction and time zone difference, you can access on-demand videos to this entire event, including synced audio/video and slides.

All posters will be in PDF format. You can visit them, upload and interact directly with the poster presenter. You can also exchange with speakers via direct or private exchange during the conference.


We will keep you informed of any new decision.

Using live imaging to investigate the causes and consequences of mitochondrial toxicity in the kidney

Andrew-Hall---Targeting-Mitochondria-2018Dr Andrew Hall from University of Zurich, Switzerland will participate to the congresss and talk about "Using live imaging to investigate the causes and consequences of mitochondrial toxicity in the kidney" during the 9th World Congress on Targeting Mitochondria 2018 which will be held in Berlin next October 23-25.


Dr. Andrew Hall summarized their team's research on Mitochonddria as: "Mitochondrial toxicity from therapeutic drugs is a common cause of acquired kidney disease in humans, but in most cases the pathogenic mechanisms are not well understood. Our group uses live imaging techniques, including intravital microscopy, and computational analysis to investigate how toxins alter mitochondrial function and dynamics in kidney tubular cells in real-time, and the downstream consequences of mitochondrial dysfunction on important physiological processes, such as solute transport and calcium signaling."

If you would like to know more about Targeting Mitochondria Congress: